At a White House event Thursday, President Trump announced deals with drugmakers Novo Nordisk and Eli Lilly to offer their popular GLP-1 obesity and diabetes drugs at lower prices for some Americans, namely some on Medicare and Medicaid plans
While studies suggest Ozempic generally doesnt require dose changes based on kidney function for many with kidney disease, careful monitoring is essential, especially given reports of acute kidney injury during initial or intermediate doses, particularly in those with pre-existing kidney issues
When this peptide gets released in the gut, it slows the gut, and sends a signal to your brain that says Im full
Theres only one phase one trial thats registered right now, and its been registered since 2016, and nothing has been updated on that registration, so that tells you something as well
Do appetite effects get stronger over time